The revenue of the in-vitro diagnostics market in 2017 was estimated at $63bn and was dominated by the Point of Care Testing Segment. The Molecular Diagnostics segment will be the fastest growing segment in the first-half of the forecast period.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 263-page report you will receive 107 tables and 81 figures– all unavailable elsewhere.
The 263-page report provides clear detailed insight into the in-vitro diagnostics market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• In-Vitro Diagnostics market forecasts from 2018-2028
• This report breaks down the revenue forecast for the main submarkets by Type:
• Point of care
• Clinical chemistry
• Immunochemistry
• Haematology
• Microbiology
• Molecular Diagnostics
• Flow Cytometry
• Others
• The Point of Care Diagnostic submarket is further segmented into:
• Blood Glucose Testing
• Infectious Disease Testing
• Rapid Coagulation Testing
• Cholesterol Testing
• Pregnancy Testing
• The Clinical Chemistry submarket is further segmented into:
• Basic Metabolic Panel
• Electrolyte Panel
• Liver Profile
• Lipid Profile
• Thyroid Function Test
• The Immunochemistry submarket is further segmented into:
• ELISA
• Immuno-PCR
• Rapid Test
• Western Blot
• Enzyme linked Immunospot Assay
• This report breaks down the revenue forecast for the main submarkets by Application:
• Infectious Diseases
• Diabetes
• Cardiology
• Autoimmune Diseases
• Renal Diseases
• Pharmacogenomics
• HIV/AIDS
• Other Applications
• This report breaks down the revenue forecast for the main submarkets by Products & Services:
• Analyzers
• Reagents
• Software & Services
• This report breaks down the revenue forecast for the main submarkets by End-User:
• Lab Testing
• Hospital Testing
• University Testing
• Home Care Testing
• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• Americas: US, Canada, Mexico, Brazil, Rest of Americas
• Europe: UK, Germany, France, Spain, Italy, Russia, Rest of Europe
• Asia: India, China, Japan, Rest of Asia
• RoW
Each regional and national market is further segmented by type.
• Our study includes SWOT analysis and STEP analysis of the in-vitro diagnostics market.
• Our study discusses the selected leading companies that are the major players in the in-vitro diagnostics market:
• Abbott Diagnostics
• Agilent Technologies
• Becton, Dickinson and Company (BD)
• BioMerieux
• Bio-Rad
• Danaher Corporation
• DiaSorin Diagnostics s.p.a
• Roche Diagnostics
• Siemens Diagnostics
• Sysmex Corporation
Visiongain’s study is intended for anyone requiring commercial analyses for the in-vitro diagnostics market. You find data, trends and predictions.
Buy our report today In-Vitro Diagnostics World Market Analysis : Point of Care, Clinical Chemistry, Immunochemistry, Haematology, Microbiology, Molecular Diagnostics, Flow Cytometry, Infectious Diseases, Diabetes, Cardiology, Autoimmune Diseases, Renal Diseases, Pharmacogenomics, HIV/AIDS, Reagent & Kits, Instruments, Data Management Software & Services, Hospitals, Laboratories, Home Care Testing, Research Institutes, Blood Glucose Testing, Infectious Disease Testing, Rapid Coagulation Testing, Cholesterol Testing, Pregnancy Testing, Basic Metabolic Panel, Electrolyte Panel, Liver Profile, Lipid Profile, Thyroid Function Test, ELISA, Immuno-PCR, Rapid Test, Western Blot, Enzyme linked Immunospot Assay
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Introduction to the IVD Industry and Market
1.2 Main Report Findings
1.3 This Study Provides the Following Knowledge
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Main Questions Answered by This Study
1.7 Who is This Study For?
1.8 Research Methods and Analysis
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to the IVD Market
2.1 Market Definition
2.2 Classifying In Vitro Diagnostics
2.2.1 The US Classification
2.2.2 The European Commission (EC) Classification
2.2.2.1 Introduction to the New IVD Regulation
2.2.2.2 Scope of Regulated IVD Products
2.2.2.3 Classification and conformity assessment
2.2.2.4 Identification and traceability
2.2.2.5 Performance evaluation report
2.2.2.6 Vigilance and market surveillance
2.2.2.7 Notified Bodies
2.2.2.8 Timetable for introduction and transition
2.2.3 Regulatory Issues in the IVD Market
2.2.3.1 Regulation of IVD Tests
2.2.3.2 Lack of Clarity Can be Costly
2.3 Market Segmentation
2.4 What are the Different Types of IVD Tests?
2.5 Point of care Diagnostics – The Most Prominent Type of IVD
2.6 Clinical Chemistry is increasing in Complexity
2.7 Microbiology
2.7.1 Regulatory Differences with IVD Microbiology Tests
2.8 Haematology
2.9 Immunochemistry
2.10 Molecular Diagnostics
2.11 Flow Cytometry
3. The Global In Vitro Diagnostics Market, 2018-2028
3.1 In Vitro Diagnostics Market in 2017
3.2 Global IVD Market Forecast 2018-2028
3.3 In Vitro Diagnostics Market in 2028
3.4 In Vitro Diagnostics Market Dynamics
3.4.1 Drivers
3.4.1.1 Advances in Technology Driving the IVD Market
3.4.1.2 Growing Partnership of Diagnostic companies with Pharmaceutical companies
3.4.1.3 Increased Awareness of the Need for IVD Tests
3.4.2 Restraints
3.4.2.1 Lack of Budget and Labour
4. The Global In Vitro Diagnostics Market, Industry Trends, 2018-2028
4.1 Mergers & Acquisitions in Liquid Biopsy Area
4.2 Growing Importance of Microbiome Research
4.3 Gene Editing Market to flourish during the forecast
4.4 Connectivity through Cloud Computing to drive POC testing market
4.5 IVD manufacturers to move beyond their boundaries to explore emerging markets
5. In Vitro Diagnostics Submarkets, 2018-2028
5.1 Point of Care Testing (POCT) Market, 2018-2028
5.2 POC Diagnostics: Market Forecast 2018-2028
5.3 POC Diagnostics: Market Dynamics 2018-2028
5.3.1 New Tests Targeting Biomarkers Will Be Crucial
5.3.2 Competition Driving Consolidation and Product Innovation
5.3.3 Infectious Diseases Prompting Growth of POC
5.3.4 Shortage of Manpower to boost the POCT market
5.3.5 Improved Data Analysis and Data Storage has fuelled the growth of POCT industry
5.3.6 Stringent Regulatory Policies affecting the new product launches
5.3.7 Product Recalls impacting the usage of POCT
5.4 POC Diagnostics Market by Sub-Segment, 2018-2028
5.4.1 Blood Glucose Testing: Market Forecast 2018 - 2028
5.4.2 Infectious Diseases Testing: Market Forecast 2018-2028
5.4.3 The Rapid Coagulation Testing: Market Forecast 2018-2028
5.4.4 The Rapid Cardiac Testing: Market Forecast 2018-2028
5.4.5 The Cholesterol Testing: Market Forecast 2018-2028
5.4.6 Pregnancy Testing: Market Forecast 2018-2028
5.4.7 Other POCT tests
5.5 The Global Clinical Chemistry IVD Market, 2018-2028
5.5.1 Clinical Chemistry: Market Forecast 2018-2028
5.5.2 Clinical Chemistry: Market Dynamics, 2018-2028
5.5.3 Drivers
5.5.3.1 Minimal total turnaround time
5.5.3.2 Boost in healthcare expenditure
5.5.4 Restraints
5.5.4.1 Market maturity
5.5.5 Clinical Chemistry Market by Sub-Markets, 2018-2028
5.5.5.1 Basic Metabolic Panel: Market Forecast 2018-2028
5.5.5.2 Electrolyte Panel: Market Forecast 2018-2028
5.5.5.3 Liver Function Tests: Market Forecast 2018-2028
5.5.5.4 Lipid Profile Tests: Market Forecast 2018-2028
5.5.5.5 Thyroid Function Tests: Market Forecast 2018-2028
5.5.5.6 Other Clinical Chemistry Tests: Market Forecast 2018-2028
5.6 The Global Immunochemistry IVD Market, 2018-2028
5.6.1 Immunochemistry: Market Forecast, 2018-2028
5.6.2 Immunochemistry: Market Dynamics, 2018-2028
5.6.2.1 Drivers
5.6.2.2 Restraints
5.6.3 Immunochemistry Market by Sub-Market, 2018-2028
5.6.3.1 ELISA Test: Market Forecast 2018-2028
5.6.3.2 Immuno-PCR: Market Forecast 2018-2028
5.6.3.3 Rapid Tests: Market Forecast 2018-2028
5.6.3.4 Western Blot: Market Forecast 2018-2028
5.6.3.5 Enzyme-Linked Immunospot Assay: Market Forecast 2018-2028
5.6.3.6 Other Immunochemistry Tests: Market Forecast 2018-2028
5.7 The Global Microbiology IVD Submarket, 2018-2028
5.7.1 Microbiology: Market Forecast 2018-2028
5.7.2 Microbiology Market Dynamics, 2017-2028
5.7.3 Drivers
5.7.3.1 Increase in infectious diseases
5.7.3.2 Advent of transitional technologies
5.7.4 Restraint
5.7.4.1 Availability of skilled labour
5.8 The Global Haematology IVD Market, 2018-2028
5.8.1 Haematology: Market Forecast 2018-2028
5.8.2 Haematology Market Dynamics, 2017-2028
5.8.3 Drivers
5.8.3.1 Automation of haematology devices
5.8.3.2 Growth in coagulation testing
5.8.4 Restraint
5.8.4.1 Error in the results
5.9 The Global Flow Cytometry IVD Market, 2018-2028
5.9.1 Flow Cytometry: Market Forecast 2018-2028
5.9.2 Flow Cytometry Market Dynamics, 2017-2028
5.9.3 Drivers
5.9.3.1 Technological Advancements
5.9.3.2 Augmentation of clinical application
5.9.4 Restraints
5.9.4.1 Expensive Reagents
6. In Vitro Diagnostics Markets by Application, 2018-2028
6.1 Infectious Diseases: Market Forecast 2018-2028
6.2 Diabetes IVD: Market Forecast 2018-2018
6.3 Oncology IVD: Market Forecast 2018-2028
6.4 Cardiology IVD: Market Forecast 2018 - 2028
6.5 Autoimmune Diseases IVD: Market Forecast 2018 - 2028
6.6 Pharmacogenomics IVD: Market Forecast 2018 - 2028
6.7 Endocrine IVD: Market Forecast 2018 - 2028
6.8 HIV/AIDS IVD: Market Forecast 2018 - 2028
6.9 Other Diseases IVD: Market Forecast 2018-2028
7. In Vitro Diagnostics by Products & Services, 2018-2028
7.1 Analyzers: Market Forecast 2018 - 2028
7.2 Reagents: Market Forecast 2018 - 2028
7.3 Software and Services: Market Forecast 2018 – 2028
8. In Vitro Diagnostics Market by End User, 2018-2028
8.1 Lab Testing: Market Forecast 2018-2028
8.2 Hospital Testing: Market Forecast 2018-2028
8.3 University Testing: Market Forecast 2018-2028
8.4 Home Care Testing: Market Forecast 2018-2028
9. Leading National IVD Markets, 2018-2028
9.1 Regional Breakdown of the Global IVD Market, 2017
9.2 Regional Breakdown of the Global IVD Market, 2028
9.3 Country wise Breakdown of the Global IVD Market, 2017
9.4 Country wise Breakdown of the Global IVD Market, 2028
9.5 The American IVD Market Forecast, 2018-2028
9.5.1 The US IVD Market Forecast, 2018-2028
9.5.2 The Canada IVD Market Forecast, 2018-2028
9.5.3 The Mexican IVD Market Forecast, 2018-2028
9.5.4 The Brazil IVD Market Forecast, 2018-2028
9.5.6 Rest of Americas IVD Market Forecast, 2018-2028
9.6 The European Nations IVD Market Forecast, 2018-2028
9.6.1 The U.K. IVD Market Forecast, 2018-2028
9.6.2 The Germany IVD Market Forecast, 2018-2028
9.6.3 The French IVD Market Forecast, 2018-2028
9.6.4 The Italian IVD Market Forecast, 2018-2028
9.6.5 The Spanish IVD Market Forecast, 2018-2028
9.6.6 The Russian IVD Market Forecast, 2018-2028
9.6.7 Rest of Europe (ROE) IVD Market Forecast, 2018-2028
9.7 Asia Region IVD Market Forecast, 2018-2028
9.7.1 Japan IVD Market Forecast, 2018-2028
9.7.2 China IVD Market Forecast, 2018-2028
9.7.3 India IVD Market Forecast, 2018-2028
9.7.4 Rest of Asia IVD Market Forecast, 2018-2028
9.8 Rest of the World Market Forecast, 2018-2028
10. Leading Companies in In-Vitro Diagnostics Market 2018-2028
10.1 Agilent Technologies
10.1.1 Agilent Technologies, Revenues ($bn), 2015-2017
10.1.2 Agilent Technologies, Revenues ($bn) by Product & Service, 2015-2017
10.1.3 Agilent Technologies, Revenues (%) by Product & Service, 2015-2017
10.1.4 Agilent Technologies, Revenues (%) by Segment, 2015-2017
10.1.5 Agilent Technologies, Revenues (%) by Geography, 2017
10.2 Roche Diagnostics
10.2.1 Sales and Recent Performance Analysis, 2018
10.2.2 Sales and Recent Performance Analysis by Diagnostic Division Business Area, 2018
10.2.3 Sales of Diagnostic Division by Region, 2018
10.2.4 Sales of Diagnostic Division Sub-Market by Region 2018
10.2.4.1 Centralized and Point of Care Solutions, 2018
10.2.4.2 Diabetes Care Regional Sale, 2018
10.2.4.3 Molecular Diagnostics Regional Sale, 2018
10.2.4.4 Tissue Diagnostics Regional Sale, 2018
10.2.5 M&As of Diagnostic Division, 2018
10.2.5.1 Roche Diagnostics acquires mySugr GmbH
10.2.5.2 Roche Diagnostics acquires Viewics, Inc.
10.3 Danaher Corporation
10.3.1 Danaher Corporation, Sales and Performance Analysis, 2018
10.3.2 M&As of Diagnostic Division, 2018
10.4 Abbott Diagnostics
10.4.1 Sales and Recent Performance Analysis, 2018
10.4.2 Sales and Recent Performance Analysis by Segments, 2018
10.4.3 Sales and Recent Performance Analysis by Geography, 2018
10.4.4 Acquisitions of Abbott Laboratories, 2018
10.4.5 New Product Launches, 2018
10.5 Siemens Diagnostics
10.5.1 Siemens Sales and Recent Performance Analysis, 2018
10.5.2 Sales and Recent Performance Analysis by Market Share (%), 2018
10.5.3 Siemens Healthcare Sector, 2017
10.5.4 New Product & R&D
10.6. Sysmex Corporation
10.6.1 Sysmex Total Sales Revenue ($bn), 2018
10.6.2 Sysmex Revenue by Segments ($bn), 2017
10.6.3 Business Alliance
10.7. Becton, Dickinson and Company (BD)
10.7.1 BD Sales and Recent Performance Analysis, 2018
10.7.2 BD Sales and Recent Performance Analysis by Geography 2018
10.8 BioMerieux
10.8.1. BioMerieux Sales and Recent Performance Analysis, 2018
10.8.2 BioMerieux Sales and Recent Performance Analysis by Segment 2018
10.8.3 BioMerieux Sales and Recent Performance Analysis by Geography, 2018
10.8.4 BioMerieux Products & Services, 2018
10.9 Bio-Rad
10.9.1 Bio-Rad Sales and Recent Performance Analysis, 2018
10.10 DiaSorin Diagnostics s.p.a
10.10.1 DiaSorin Sales and Recent Performance Analysis, 2018
10.10.2 DiaSorin Sales and Recent Performance Analysis, By Technology, 2018
10.10.3 DiaSorin Acqusitions & Collaborations, 2018
10.11 Qiagen N.V.
10.11.1 Qiagen Sales & Performance Analysis, 2018
10.11.2 Qiagen Revenue by Product Category, 2018
10.11.3 Qiagen Revenue by Geography, 2018
10.11.4 Qiagen Acquisitions & Agreements, 2018
10.12. Myriad Genetics
10.12.1 Myriad Genetics, Sales and Recent Performance Analysis, 2018
10.13 Thermo Fisher Scientific
10.13.1 Thermo Fisher Scientific Sales and Recent Financial Performance, 2018
10.13.2 Thermo Fisher Scientific Revenues by Segments 2018
10.13.3 Thermo Fisher Scientific Revenues by Geography, 2018
11. SWOT Analysis of the IVD Market, 2018
11.1 In Vitro Diagnostics: Industry Trends
11.2 Strengths of the IVD Market, 2018
11.2.1 Patient Demographics will be a Major Driver
11.2.2 Innovation Will Continue
11.3 Weaknesses
11.3.1 Regulatory Board Approvals May be Problematic
11.3.2 Reimbursement Issues Could Restrain Growth
11.4 Opportunities
11.4.1 Globalisation Creates a Wealth of Opportunity in Emerging Economies
11.4.2 Molecular Diagnostics Will have Increased Prominence
11.5 Threats
11.5.1 Medical Device Excise Tax in the US
11.5.2 Convergence
12. STEP Analysis of the IVD Market, 2018
12.1 Social Factors
12.2 Technological Factors
12.3 Economic Factors
12.4 Political Factors
13. Conclusions from the Research
13.1 Overview of the IVD Market
13.2 Submarket Breakdown
13.3 National IVD Market Outlook, 2018-2028
13.4 Leading Companies in the Global IVD Market
13.5 Future Outlook and Concluding Remarks
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 2.1: POC Diagnostics -Advantages and Disadvantages
Table 3.1: Global IVD Market by Type: Revenue ($bn), Market Share (%), 2017
Table 3.2: Global IVD Market Forecast by Type: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 3.3: Global IVD Market by Type: Revenue ($bn), Market Share (%), 2028
Table 5.1 The POCT Diagnostics Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.2 Global POC Diagnostics Market by Type: Market Share (%), 2017
Table 5.3 Blood Glucose Testing Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.4 Infectious Disease Testing Products: 2017
Table 5.5 Infectious Disease Testing Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.6 Rapid Coagulation Testing Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.7 Rapid Cardiac Testing Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.8 Cholesterol Testing Kits, 2018
Table 5.9 Cholesterol Testing Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.10 Pregnancy Testing Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.11 Other POCT Testing Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.12 Clinical Chemistry Market Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.13 Clinical Chemistry Market by Type: Revenue ($bn), Market Share (%), 2017
Table 5.14 Basic Metabolic Panel Market Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.15 Electrolyte Panel Market Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.16 Liver Function Test Market Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.17 Lipid Profile Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.18 Thyroid Function Test Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.19 Other Clinical Chemistry Tests Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 5.20 The Global Immunochemistry IVD Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.21. Global Immunochemistry Market by Type: Revenue ($bn), Market Share (%), 2017
Table 5.22 Global Immunochemistry Market by Type: Market Share (%), 2017
Table 5.23 The ELISA Test Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.24 The Immuno-PCR Market: Revenue ($bn), AGR (%), CAGR (%),2017-2028
Table 5.25 The Immuno- Rapid Test Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.26 The Western Blot Test Market: Revenue ($bn), AGR (%), CAGR (%). 2017-2028
Table 5.27 The ELISA Immunospot Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.28 The Other Immunochemistry Tests Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.29 The Global Microbiology Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.30 The Global Haematology Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 5.31 The Global Flow Cytometry Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 6.1 The Infectious Diseases IVD Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.2 The Diabetes IVD Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.3 The Oncology IVD Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.4 The Cardiology IVD Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.5 The Autoimmune IVD Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.6 The Pharmacogenomics IVD Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.7 The Endocrine IVD Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.8 The HIV/AIDS Market by Application: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 6.9 The Other Diseases IVD Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 7. 1 Global IVD Analyzers Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 7.2 Global IVD Reagents Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 7.3 Global IVD Software & Services Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 8.1 Global IVD Lab Testing Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 8.2 Global IVD Hospital Testing Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 8.3 Global University Lab Testing Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 8.4 Global Home Care Testing Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.1: Global IVD Market by Geography by Region, Revenue ($bn), Market Share (%), 2017
Table 9.2: Global IVD Market by Region: Revenue ($bn), Market Share (%), 2028
Table 9.3: Global IVD Market by Country: Revenue ($bn), Market Share (%), 2017
Table 9.4: Global IVD Market by Country: Revenue ($bn), Market Share (%), 2028
Table 9.5 The American IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.6 The American IVD Market by Country: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.7 The US IVD Market by Type: Revenue($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.8 The Canadian IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.9 The Mexican IVD Market by Type: Revenue($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.10 The Brazil IVD Market by Type: Revenue($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.11 The Rest of Americas IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.12 The European IVD Market by Country: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.13 The European IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.14 The U.K. IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.15 The Germany IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.16 The French IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.17 The Italian IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.18 The Spanish IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.19 The Russian IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.20 The Rest of Europe IVD Market by Type: Revenue($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.21 The Asian IVD Market by Country: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.22 The Asian IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.23 The Japanese IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.24 The Chinese IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.25 The Indian IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.26 The Rest of Asia IVD Market by Type: Revenue ($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.27 The ROW IVD Market: Revenue($bn), AGR (%) and CAGR (%), 2017-2028
Table 9.28 The ROW IVD Market by Type: Revenue($bn), AGR (%) and CAGR (%), 2017-2028
Table 10.1 Agilent’s Total Net Revenue by Product & Service ($bn, 2015-2017
Table 10.2 Agilent’s Total Net Revenue by Product & Service (%), 2015-2017
Table 10.3 Agilent’s Total Net Revenue by Segment ($bn), 2015-2017
Table 10.4 Roche by Division: Revenue ($bn), 2016-2017
Table 10.5 Roche by Division: Revenue ($bn), 2016-2017
Table 10.6 Roche by Division: Revenue by Region ($bn), 2016-2017
Table 10.7 Roche Diagnostic Division Sales by Emerging Market ($bn), 2016-2017
Table 10.8 Centralized and Point of Care Solutions: Revenue ($bn), 2016-2017
Table 10.9 Diabetes Care Regional Sales: Revenue ($bn), 2016-2017
Table 10.10 Molecular Diagnostic Regional Sales: Revenue ($bn), 2016-2017
Table 10.11 Tissue Diagnostic Regional Sales: Revenue ($bn),2016-2017
Table 10.12 Danaher Corp. by Division: Revenue ($bn),2016-2017
Table 10.13 Abbott Laboratories by Division: Revenue ($bn), 2015-2017
Table 10.14 Abbott Laboratories by Geography: Revenue ($bn), 2015-2017
Table 10.15 Sales and Recent Performance Analysis Revenue by Sector, ($bn), 2016-2017
Table 10.16 Sales and Recent Performance Analysis Revenue by Sector, ($bn), 2016-2017
Table 10.17 BD Sales and Recent Performance Analysis Revenue by Sector, ($bn), 2015-2017
Table 10.18 BD Sales and Recent Performance Analysis Revenue by Life Sciences Organizational Units, ($bn), 2015-2017
Table 10.19 BD Sales and Recent Performance Analysis Revenue by Geography ($bn), 2015-2017
Table 10.20 BioMerieux Major Products, by Segment, 2017
Table 10.21 Bio-Rad Net Sales by Segment ($bn), 2015- 2017
Table 10.22 Bio-Rad Net Sales by Geography ($bn), 2015- 2017
Table 10.23 DiaSorin Net Sales ($bn) by Geography, 2015- 2017
Table 10.24 Qiagen Net Sales ($bn), by Product Category 2015- 2017
Table 10.25 Qiagen Net Sales ($bn) by Geography, 2015- 2017
Table 10.26 Myriad Genetics Net Sales ($m), 2015- 2017
Table 10.27 Thermo-Fisher Scientific Revenues by Segment ($bn), 2016- 2017
Table 11.1 Global IVD Market: SWOT Analysis, 2017
List of Figures
Figure 1.1 In Vitro Diagnostics Market Segmentation, 2017
Figure 3.1 Global IVD Market by Type: Market Share (%) 2017
Figure 3.2 Global IVD Market by Type: Market Share (%) 2028
Figure 3.3 IVD Market Dynamics, 2017 (Drivers & Restraints)
Figure 5.1 The POCT Diagnostics Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.2: Drivers & Restraints for POCT Market, 2018
Figure 5.3 POCT Diagnostics Market by Type: Market Share (%), 2017
Figure 5.4 Blood Glucose Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.5 Infectious Disease Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.6 Rapid Coagulation Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.7: Rapid Cardiac Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.8 Cholesterol Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.9 Pregnancy Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.10: Other POCT Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.11 Clinical Chemistry Market Revenue ($bn), AGR (%), 2017-2028
Figure 5.12 Drivers & Restraints for Clinical Chemistry Market, 2018
Figure 5.13 Clinical Chemistry Market by Type: Market Share (%), 2017
Figure 5.14 Basic Metabolic Panel Market Revenue ($bn), AGR (%), 2017-2028
Figure 5.15 Electrolyte Panel Market Revenue ($bn), AGR (%), 2017-2028
Figure 5.16 Liver Function Test Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.17 Lipid Profile Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.18 Thyroid Function Test Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.19 Other Clinical Chemistry Tests Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.20 The Global Immunochemistry IVD Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.21 Drivers & Restraints for Immunochemistry Market, 2018
Figure 5.23 The ELISA Test Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.24 The Immuno-PCR Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.25 The Immuno- Rapid Test Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.26 The Western Blot Test Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.27 The ELISA Immunospot Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.28 The Other Immunochemistry Tests Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.29 The Global Microbiology Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.30 Drivers & Restraints for Microbiology Market, 2018
Figure 5.31 The Global Haematology Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.32 Drivers & Restraints for Haematology Market, 2018
Figure 5.33 The Global Flow Cytometry Market: Revenue ($bn), AGR (%), 2017-2028
Figure 5.34 Drivers & Restraints for Flow Cytometry Market, 2018
Figure 6.1 The Infectious Diseases Market: Revenue ($bn), AGR (%), 2017-2028
Figure 6.2 The Diabetes IVD Market by Application: Revenue ($bn), AGR (%), 2017-2028
Figure 6.3 The Oncology IVD Market by Application: Revenue ($bn), AGR (%), 2017-2028
Figure 6.4 The Cardiology IVD Market by Application: Revenue ($bn), AGR (%), 2017-2028
Figure 6.6 The Autoimmune IVD Market by Application: Revenue ($bn), AGR (%), 2017-2028
Figure 6.7 The Pharmacogenomics IVD Market by Application: Revenue ($bn), AGR (%), 2017-2028
Figure 6.8 The Endocrine IVD Market by Application: Revenue ($bn), AGR (%), 2017-2028
Figure 6.9 The HIV/AIDS Market by Application: Revenue ($bn), AGR (%), 2017-2028
Figure 6.10 The Other Diseases IVD Market: Revenue ($bn), AGR (%), 2017-2028
Figure 7.1 In Vitro Diagnostics by Products & Services (%), 2017
Figure 7.2 In Vitro Diagnostics by Products & Services (%), 2028
Figure 7.3 Global IVD Analyzers Market: Revenue ($bn), AGR (%), 2017-2028
Figure 7.4 Global IVD Reagents Market: Revenue ($bn), AGR (%), 2017-2028
Figure 7.5 Global IVD Software & Services Market: Revenue ($bn), AGR (%), 2017-2028
Figure 8.1 In Vitro Diagnostics Market by End-User (%), 2017
Figure 8.2 In Vitro Diagnostics Market by End-User (%), 2028
Figure 8.3 Global IVD Lab Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 8.4 Global IVD Hospital Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 8.5 Global University Lab Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 8.6 Global Home Care Testing Market: Revenue ($bn), AGR (%), 2017-2028
Figure 9.1 Global IVD Market by Geography by Region: Market Share (%), 2017
Figure 9.2 Global IVD Market by Region: Market Share (%), 2028
Figure 9.3 Global IVD Market by Country: Market Share (%), 2017
Figure 9.4 Global IVD Market by Country: Market Share (%), 2028
Figure 10.1 Agilent Technologies, Revenue ($bn), 2015-2017
Figure 10.2 Agilent Technologies Revenue Share by Geography (%), 2017
Figure 10.3 Roche by Division: Revenue Share (%), 2017
Figure 10.4 Roche Diagnostics by Business Area: Revenue Share (%), 2017
Figure 10.5 Danaher Corp. by Division: Revenue Share (%), 2017
Figure 10.6 Abbott Laboratories, Revenue ($bn), 2017
Figure 10.7 Siemens’s Segment Revenue by Market Share (%), 2017
Figure 10.8 Sysmex Revenue ($bn), 2016-2017
Figure 10.9 Sysmex Revenue by Region Market Share (%), 2017
Figure 10.10 Sysmex Revenue by Region Breakdown of Overseas Market Share (%), 2017
Figure 10.11 BD Revenue ($bn) 2015-2017
Figure 10.12 BioMerieux Revenue ($bn), 2015-2017
Figure 10.13 BioMerieux Revenue ($bn) by Segment, 2017
Figure 10.14 BioMerieux Revenue ($bn) by Geography, 2017
Figure 10.15 Bio-Rad Revenue ($bn), 2015-2017
Figure 10.16 DiaSorin Revenue ($bn) 2016-2017
Figure 10.17 Qiagen Net Sales Revenue ($bn), 2015-2017
Figure 10.18 Thermo Fisher Scientific Net Sales Revenue ($bn), 2015-2017
Figure 10.19 Thermo Fisher Scientific Net Sales Revenue (%), by Geography 2017
Figure 13.1 Global IVD Market by Major Players: Market Share (%), 2017
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
